RxDoctor Payments Data

Shelley Wigler

Gerontology · Newtown, PANPI 1962111245

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,171, 9.1 times the $240 reported in 2023. Among gerontology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,546in general payments, 2019–2025

Across 182 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$717
  • AbbVie$335
  • Bayer$325
  • Sumitomo Pharma America, Inc.$291
  • Novo Nordisk$253
  • Lilly USA, LLC$176
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,546100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,546 in reported general payments places this provider in the 90th percentile of 383 gerontology providers in Pennsylvania.

See all gerontology providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide33$35,342
Duloxetine Hcl13$909
Pravastatin Sodium15$388
Ibandronate Sodium11$347
Tamsulosin Hcl14$337
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav38$306
Famotidine26$282
Fluticasone Propionate24$273
Potassium Chloride16$204
Bupropion XlBupropion Hcl12$204
Furosemide25$193
Atorvastatin Calcium14$181
Cephalexin12$181
Methylprednisolone30$147
Prednisone27$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$176$35,34233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 383 gerontology providers in Pennsylvania.

Other gerontology in Newtown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →